Stevanato Group S.p.A.STVN

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$21.38
Market cap
$6.5B
P/E
—
Revenue (FY)
$1.2B
Net income
$139.8M
Dividend yield
0.29%
1-year total return
-14.5%
Net margin
11.8%
Revenue growth
7.4%
Debt / equity
—

What Stevanato Group S.p.A. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$662.0M$843.9M$983.7M$1.1B$1.1B$1.2B
Net income$78.5M$134.3M$142.8M$145.6M$117.8M$139.8M
Free cash flow$66.1M$25.6M-$131.7M-$328.0M-$146.8M$22.3M

More on STVN.

Figures from Stevanato Group S.p.A.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.